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Abstract 
Background: Environmental lead and cadmium exposure is associated with higher risk 
of several age-related chronic diseases, including cardiovascular disease, chronic kidney 
disease and osteoporosis. These diseases may lead to frailty, a geriatric syndrome 
characterized by diminished physiologic reserve in multiple systems with decreased 
ability to cope with acute stressors. However, no previous study has evaluated the 
association between lead or cadmium exposure and frailty. 
Methods: Cross-sectional study among individuals aged ≥60 years who participated in 
the third U.S. National Health and Nutrition Examination Survey and had either blood 
lead (N=5,272) or urine cadmium (N=4,887) determinations. Frailty was ascertained 
with a slight modification of the Fried criteria, so that individuals meeting ≥ 3 of 5 pre-
defined criteria (exhaustion, low body weight, low physical activity, weakness and slow 
walking speed), were considered as frail. The association between lead and cadmium 
with frailty was evaluated using logistic regression with adjustment for relevant 
confounders.  
Results: Median (intertertile range) concentrations of blood lead and urine cadmium 
were 3.9 µg/dl (2.9-4.9) and 0.62 µg/l (0.41-0.91), respectively. The prevalence of 
frailty was 7.1%. The adjusted odds ratios (95% confidence interval) of frailty 
comparing the second and third to the lowest tertile of blood lead were, respectively, 
1.40 (0.96-2.04) and 1.75 (1.33-2.31). Lead concentrations were also associated with 
the frequency of exhaustion, weakness and slowness. The corresponding odds ratios 
(95% confidence interval) for cadmium were, respectively, 0.97 (0.68-1.39) and 1.55 
(1.03-2.32), but this association did not hold after excluding participants with reduced 
glomerular filtration rate: 0.70 (0.43-1.14) and 1.09 (0.56-2.11), respectively. 
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Conclusions: In the US older adult population, blood lead but not urine cadmium 
concentrations showed a direct dose-response relationship with frailty. These findings 
support that lead exposure increases frailty in older adults.  
Key words: Lead, cadmium, frailty, muscle strength  
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INTRODUCTION 
 
Frailty is a geriatric syndrome characterized by a decreased ability to cope with acute 
stressors resulting from aging-related decline in reserve and function of multiple 
physiologic systems, including the cardiovascular, metabolic, immune, endocrine, or 
nervous systems (Clegg et al. 2013). The progressive accumulation of deficits in these 
systems increases the risk of disease onset and leads to a cycle of events (i.e. 
undernutrition, sarcopenia, diminished strength or exercise intolerance) that perpetuate 
frailty. With the addition of new stressors, the cycle of frailty can easily progress to 
disability (Vermeulen et al. 2011), institutionalization (Fried et al. 2001) and death 
(Graham et al. 2009;Song et al. 2010). Given the serious consequences of frailty and its 
high frequency, which reaches 10% of individuals over 60 years and 25% of those over 
80 (Clegg et al. 2013), extensive research is being conducted to determine why some 
older adults become frail, and to identify preventable risk factors and mechanistic 
pathways. Despite this effort, few studies have evaluated the role of environmental 
contaminants on the risk of frailty, and most of them have focused on the effects of air 
pollution (Eckel et al. 2012;Myers et al. 2013). 
 
The Environmental Protection Agency (EPA) has identified common environmental 
exposures that may especially harm the health of older adults, including metals, 
pesticides, water contaminants or air particles. For some contaminants (i.e. organic 
pollutants, certain metals) this increased risk may be related to bioaccumulation over the 
lifetime. Higher vulnerability in older adults may also partly result from age-related 
alterations in cellular function which impair the capability to maintain physiologic 
homeostasis (Geller and Zenick 2005). Additionally, aging is associated with major 
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changes in body composition that could influence the absorption and distribution of 
environmental chemicals in human tissues (Nordberg et al. 2007). 
 
Lead and cadmium are two toxic metals widely distributed in the environment that 
accumulate in the human body, resulting in chronic endogenous exposure tissues  
(Nordberg et al. 2007). Increasing evidence supports the contribution of environmental 
lead and cadmium to the development of several age-related chronic diseases, including 
cardiovascular disease (Navas-Acien et al. 2007;Tellez-Plaza et al. 2013b), chronic 
kidney disease (Navas-Acien et al. 2009), and osteoporosis (Engstrom et al. 
2011;Gallagher et al. 2008;Khalil et al. 2008). Despite this evidence, and the established 
connection between these diseases and the frailty syndrome (Heuberger 2011), no 
previous studies have examined the association between lead or cadmium exposure and 
frailty. To evaluate this question, we used data from the third US National Health and 
Nutrition Examination Survey (NHANES III). We hypothesized that increasing 
concentrations of blood lead or urine cadmium are associated with increasing frequency 
of frailty in older adults.  
 
METHODS 
 
Study participants 
 
NHANES III was a multistage, stratified, clustered probability survey of the US civilian 
non-institutionalized population, conducted between 1988 and 1994 by the National 
Center for Health Statistics. The survey consisted of a household interview and a 
standardized physical examination performed in a mobile center. Our analysis was 
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initially limited to adults ≥60 years of age who had completed the physical examination 
(N=5,724). For our study, we further restricted the sample to participants who had either 
blood lead or urine cadmium determinations available (N=5,579). The study was 
approved by the NHANES Institutional Review Board (IRB), and written informed 
consent was obtained from all subjects. 
 
Study variables 
 
Lead and Cadmium 
 
Blood and spot urine samples were collected during the physical examination. All 
collection and storage materials used for metal analysis were prescreened for 
background contamination levels. Blood lead concentrations were measured by graphite 
furnace atomic absorption spectrophotometry. The limit of detection (LOD) for blood 
lead was 1 µg/dl and the interassay coefficients of variation ranged from 2.78 to 8.11%. 
For 2.8% of the participants with blood lead concentrations under the LOD, these were 
replaced by the LOD divided by the squared root of 2.  
 
Urine cadmium was measured by Zeeman effect graphite furnace atomic absorption. 
The LOD for cadmium was 0.03 µg/dl and the interassay coefficients of variation 
ranged from 2.83 to 13.57%. Cadmium was undetectable for 2.5% of the participants 
and the levels replaced by the LOD divided by the square root of 2. To account for urine 
dilution, cadmium levels were either adjusted or divided by urine creatinine (µg/g). 
Additional details regarding laboratory procedures have been described in detail (Gunter 
et al. 1996).  
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Frailty 
 
Assessment of frailty was performed using a modification of the definition developed 
by Fried and colleagues (Fried et al. 2001) in the Cardiovascular Health Study (CHS). 
Individuals meeting  ≥3 of the following criteria were considered as frail: 1) Exhaustion, 
defined as any of these responses “some difficulty”, “much difficulty” or “unable to do 
it” to the question “How much difficulty do you have walking from one room to the 
other on the same level?”; 2) Low body weight, characterized by a body mass index 
(BMI)  ≤18 kg/m2; 3) Low physical activity, considered present if the individual 
answered “less active” to the following question: “When compared to most men/women 
of your age, would you say that you are more active, less active or about the same?”; 4) 
Weakness, defined as any of these responses “some difficulty”, “much difficulty” or 
“unable to do it” to the question “How much difficulty you have lifting or carrying 
something as heavy as 10 pounds? “; 5) Slow walking speed, defined as the worse 
quintile in the eight-foot walking speed test, adjusted for sex and height (Guralnik et al. 
1994). The main modifications with respect to the CHS definition of frailty were that 
the nutrition criterion was based on low BMI rather than on weight loss in the preceding 
months, and that weakness was self-reported rather than based on the direct assessment 
of grip strength; similar modifications are common in the frailty literature, and usually 
result from the information available in each dataset. 
 
Other variables 
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We collected data from a number of variables (gender, age, education, race/ethnicity, 
tobacco smoking, number of smokers at home and number of drug treatments used) that 
may act as potential confounders because they have shown to be independently 
associated with the outcome (Fried et al. 2001; Mello Ade C et al. 2014) and with the 
exposure (Nordberg et al. 2007). Additionally, participants were asked about medical 
conditions that could be acting as mediators of the studied association (i.e previous 
history of cardiovascular disease (congestive heart failure, coronary heart disease, 
angina or stroke), hypertension, diabetes, osteoarticular disease (osteoporosis, 
rheumatoid arthritis and osteoarthritis), respiratory disease (asthma, chronic bronchitis 
or emphysema) and cancer).  
Weight and height were measured in standardized conditions, and BMI was calculated 
as weight in kg divided by squared height in m. During the medical examination, blood 
pressure was measured three times with the participant seated for 5 minutes and using 
an appropriate sized cuff. Hypertension was defined as self-reported physician diagnosis 
of high blood pressure or a mean systolic/diastolic blood pressure ≥140/90 mm Hg. 
Serum creatinine was measured using the modified kinetic Jaffe reaction, with a 
coefficient of variation that ranged between 0.2 and 1.4%. Chronic kidney disease was 
defined as a glomerular filtration rate (GFR) < 60 mL/min per 1.73 m2, estimated using 
the CKD-EPI  equation (Levey et al. 2009). Serum cotinine was measured using high 
performance liquid chromotography/atmospheric pressure chemical ionization tandem 
mass spectrometry. The LOD for serum cotinine using this method was 0.05 ng/ml and 
values under the LOD were replaced by the square root of 2.  
 
Statistical analyses  
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From the initial sample size of 5,579 individuals, we excluded 85 with missing values in 
≥3 frailty domains and 86 with missing data on potential confounders (44 on education, 
5 on BMI, 5 on the number of smokers at home, 28 on self-reported chronic conditions, 
and 4 on number of drug treatments). From the remaining 5,408 participants, for lead 
analyses we excluded 136 individuals who lacked data on blood lead and for cadmium 
analyses we excluded 521 subjects without data on urine cadmium. This led to a final 
analytical sample of 5,272 (94.5%) and 4,887 (87.6%) adults for blood lead and urine 
cadmium analyses, respectively. Study participants were similar in sociodemographic 
and frailty risk factors to the overall study population (data not shown). 
 
The association of blood lead and urine cadmium concentrations with frailty or its 
components was evaluated with odds ratios (OR) and their 95% confidence interval (CI) 
obtained from logistic regression. Three logistic models were built. Model 1 was 
unadjusted. Model 2 was adjusted for sex and age, and model 3 was additionally 
adjusted for educational level, ethnicity, BMI, tobacco smoking (never/former/current), 
number of smokers at home, cardiovascular disease, hypertension, diabetes, 
osteoarticular disease, respiratory disease, cancer and number of drug treatments. In the 
analyses, lead and cadmium were classified into tertiles, with the lowest tertile being the 
exposure reference. We also modeled ln-transformed lead and ln-transformed cadmium 
as continuous variables, and expressed the results per intertertile range increase in ln-
metal concentrations. In addition, we modeled lead and cadmium as restricted cubic 
splines with knots at the 10th, 50th and 90th percentiles.  
We conducted a number of sensitivity analyses to assess the robustness of the results. 
First, to account for current exposure to tobacco smoke, including secondhand smoke, 
that is a source of lead and cadmium (Apostolou et al. 2012;Tellez-Plaza et al. 2012), 
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we repeated the analyses with further adjustment for serum cotinine concentrations, 
among individuals with this information available (N= 4,796 for lead; N= 4,596 for 
cadmium). Second, to account for urine dilution, cadmium concentrations were divided 
by urine creatinine instead of adjusting for this variable. Third, we also performed the 
analyses without accounting for urine dilution. Fourth to rule out the potential role of 
variations in cadmium excretion related to kidney function, the analyses were also run 
only among individuals with GFR in the normal range (>60 mL/min/1.73. m2). Fifth, we 
adjusted lead models for cadmium concentrations and cadmium models for lead 
concentrations, and we evaluated for potential interactions among both metals. Finally, 
in exploratory analyses, we evaluated the consistency of the findings across participant 
subgroups, we evaluated for potential interactions by sex, age, education, ethnicity, 
BMI, tobacco smoke, number of smokers at home and serum cotinine concentrations by 
adding interaction terms and then generating stratum-specific estimates.  
Statistical analyses were performed with the STATA v.13.0 software (Stata Corp, 
College Station, TX) by using the survey procedures to account for the complex 
sampling design in NHANES III 
RESULTS 
 
The median (intertertile range) concentrations of blood lead and urine cadmium were 
3.9 µg/dl (2.9-4.9) and 0.62 µg/l (0.41-0.91), respectively. Blood lead concentrations 
were higher among men, non-Hispanic black, participants with lower education or 
lower BMI, ever smokers, those living with at least one smoker, as well as in those with 
decreased GFR and chronic respiratory disease (table 1). Urine cadmium concentrations 
were higher in younger participants, non-hispanic blacks, current smokers, individuals 
living with smokers, with lower education, lower BMI, decreased GFR, and in those 
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diagnosed with cardiovascular disease or chronic respiratory disease (table 1). 
Correlation among blood lead and urine cadmium was low (r=0.20), 
 
The prevalence of frailty was 7.1%. Frailty was more common among women, 
participants ≥74 years of age, non-Hispanic black and Mexican-American participants, 
and participants with lower education. After multivariate adjustment, the OR (95%CI) 
of frailty comparing the second and third tertiles of blood lead to the lowest tertile were, 
respectively, 1.40 (0.96-2.04) and 1.75 (1.33-2.31); (model 3, table 2). The 
corresponding results for cadmium were 0.97 (0.68-1.39) and 1.55 (1.03-2.32). The 
odds ratio for frailty associated with an intertertile range increase in blood lead was 1.20 
(95%CI 1.08-1.33), and the corresponding odds ratio for an intertertile increase in urine 
cadmium was 1.30 (95% CI 0.94-1.81).. Further adjustment for serum cotinine (for both 
lead and cadmium) or dividing cadmium by creatinine instead of adjusting for log-
transformed urine creatinine provided similar results (models 4 and 5, table 2). When 
restricting the analyses to individuals with normal GFR, the results were similar for lead 
but no association was observed between cadmium and frailty (model 7, table 2); in this 
subgroup of participants the OR (95%CI) of frailty for cadmium tertiles 2 and 3 
compared to the lowest tertile were 0.70 (0.43-1.14) and 1.09 (0.56-2.11) (model 7, 
table 2). 
 
In spline regression models (figure 1), the dose-response relationship was progressive 
over the range of blood lead concentrations (p value for the nonlinear component=0.46), 
while the association with cadmium showed a nonlinear pattern (p values for the 
nonlinear component <0.01 in model B among the total study sample, and 0.03 in model 
C among individuals with normal GFR).  
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The most prevalent frailty components were weakness and slowness, while low BMI 
was the least frequent. Figure 2 presents the results for the association between the 
studied metals and the five frailty criteria. Analyses for cadmium are based on 
participants with normal estimated GFR. Individuals in the highest tertile of blood lead 
concentrations showed an increased frequency of exhaustion (OR 1.72; 95%CI 1.25-
2.37), weakness (OR 1.30; 95%CI 1.00-1.73) and slowness (OR 1.29; 95%CI 1.00-
1.58). Urine cadmium levels were only associated with greater frequency of low BMI 
(OR comparing the highest to lowest tertile: 2.56; 95%CI: 1.21-7.74).  
  
In interaction analyses, results for lead were consistent across all participant´s 
subgroups evaluated, including smoking status and cotinine concentrations (figure 3). 
Similarly, no effect modification by morbidity status was observed. We were 
particularly interested in evaluating potential effect modification by osteoporosis, as 
lead is stored in bones. The association of lead with frailty was somewhat stronger 
among women with osteoporosis: the OR (95% CI) for frailty for the second and third 
tertiles compared to the lowest one were: 1.86 (1.06-3.28) and 4.23 (1.64-10.88) in 
women with osteoporosis and 1.40 (0.87-2.27) and 2.12 (1.00-7.41) in women without 
osteoporosis (p interaction: 0.23). For cadmium, there was effect modification by 
tobacco smoking (p=0.02), with results suggesting that a positive association between 
this metal and frailty may be limited to current smokers (OR of frailty for an intertertile 
increase in urine cadmium among smokers: 2.85; 95%CI: 1.00-8.14 in individuals with 
normal GFR). No changes in the results were observed when lead models were adjusted 
for cadmium or when cadmium levels were adjusted for lead. 
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DISCUSSION 
 
In the US older adult population, blood lead concentrations showed a positive dose-
response relationship with frailty. For cadmium, no overall association with frailty was 
found but there was was some evidence of a putative adverse relationship only at high 
exposure levels. 
 
Lead and cadmium may influence the risk of frailty through several mechanisms. First, 
there is experimental evidence that these metals increase oxidative stress and 
inflammation (Jomova and Valko 2011), which, in turn, play an important role in the 
development of frailty. Specifically, frail individuals have elevated concentrations of 
biomarkers of oxidative-stress (malondialde-Hyde, 8-oxo-7,8-dihydro-2´-
deoxyguanosine (Ingles et al. 2014;Wu et al. 2009)) and inflammation (IL-6, C-reactive 
protein, fibrinogen (Gale et al. 2013;Li et al. 2011)). Second, exposure to lead and 
cadmium has been related to a higher risk of several pathologic conditions that are also 
linked to frailty. Environmental exposure to lead in the elderly has been associated with 
cognitive decline (Bandeen-Roche et al. 2009;Grashow et al. 2013;Nordberg et al. 
2000;Power et al. 2014;Shih et al. 2006;van Wijngaarden et al. 2011), impaired motor 
skills (Grashow et al. 2013), increased blood pressure (Perlstein et al. 2007), ischemic 
heart disease (Jain et al. 2007), decreased renal function (Tsaih et al. 2004), falls and 
fractures in women (Khalil et al. 2008), hearing loss (Park et al. 2010) and vision 
problems (Schaumberg et al. 2004;Wu et al. 2014). Cadmium, for which fewer studies 
have been conducted in the elderly, has also been associated with an increased risk of 
atherosclerotic plaques (Fagerberg et al. 2012), peripheral artery disease (Tellez-Plaza et 
al. 2013a), osteoporosis (Engstrom et al. 2011;Gallagher et al. 2008) and macular 
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degeneration (Shiue 2013;Wu et al. 2014). In addition, a decrease in muscle mass and 
muscle strength, which are components of frailty (Cesari et al. 2006), might also 
contribute to the observed associations. Thus, to explore this possibility in the study 
sample, we estimated muscle mass with the formula proposed by Janssen et al. (2002) 
and observed that a 1% increase in blood lead concentrations was associated with a 
decrease of 0.72% (95%CI -1.27; -0.16) in muscle mass, while a 1% increase in urine 
cadmium was linked to a reduction of 0.65% (95%CI -1.24; -0.07). These findings 
suggest that lead and cadmium could increase the risk of frailty through alterations in 
the musculoskeletal system.  
 
No previous study has evaluated the association between heavy metals and frailty. 
However, two reports from the continuous NHANES (1999-2004) have explored the 
link of blood lead (Ji et al. 2013) and urine cadmium (Lang et al. 2009) with mobility 
outcomes among the elderly population. The first of these studies (Ji et al. 2013), 
reported that walking speed decreased with increasing blood lead concentrations in 
women, but not in men. Contrary to these results, we found an association between 
blood lead concentrations and low gait speed in both men and women (data not shown). 
The second study (Lang et al. 2009) found a positive crude association between urine 
cadmium and “self-reported problems with walking a quarter of a mile”, but this 
association was not maintained after adjustment for urine creatinine. Lastly, in the VA 
Normative Aging Study, bone lead concentration was associated with reduced fine 
motor performance over a 30-month follow-up (Grashow et al. 2013).  
 
More than 90% of lead is accumulated in the bones, from where it can be released to 
blood. Blood lead, the most commonly used biomarker of lead exposure, has a 
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relatively short half-life, and reflects both recent exogenous exposure as well as chronic 
exposure from mobilization of bone stores tissues (Skerfving and Bergdahl 2007). 
Under conditions of accelerated bone turnover and mineral loss (i.e. postmenopausal 
osteoporosis; ageing-related loss of bone mass), lead stored in bones throughout life is 
released into circulation, increasing the correlation between blood lead concentrations 
and chronic exposure, as measured by patella lead levels (Tsaih et al. 2001). In this 
sense, it is interest to note that the magnitude of the observed effects in our population 
tended to be higher among older individuals and among women who had been 
previously diagnosed with osteoporosis, although effect modification was not 
statistically significant. 
 
Cadmium is a cumulative element with a biological half-life of more than 10 years, and 
urine cadmium is a good biomarker of long-term exposure (Jarup and Akesson 2009). 
Recent studies have suggested that cadmium bioaccumulation may only occur until age 
60, when urine cadmium concentrations would level off or even decrease due to 
physiological variations in renal function (Chaumont et al. 2013). It is difficult to 
anticipate how these variations with age could affect the interpretation of our results. In 
any case, given that the association between cadmium and frailty disappeared after 
excluding participants with reduced GFR, it is possible that the observed results in the 
total study sample reflected the underlying association between kidney disease and 
frailty. Accordingly, Wilhelm-Leen and colleagues (2009) recently reported a positive 
association between chronic kidney disease and frailty using data from the III 
NHANES. Thus, future prospective studies should exclude individuals with reduced 
kidney function at study entry. Special attention should be paid to current smokers, in 
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whom the observed association may reflect the combined toxic effect of cadmium and 
other tobacco chemicals.  
 
Strengths of this study included the large sample, which was representative of the US 
general population aged ≥ 60 years, the high quality laboratory methods, as well as the 
number of potential confounders evaluated. However, this study also had several 
limitations. First, NHANES III was a cross-sectional study so causal relationships 
cannot be established.  However, since blood lead and urine cadmium reflect, at least 
partially, chronic exposure to these metals, and given that the life expectancy of frail 
individuals is limited, it is reasonable to assume that the exposures preceded the 
development of frailty. Second, the study sample did not include institutionalized 
individuals, so the study results may not apply to this population group. Third, we used 
a single spot urine sample to measure cadmium concentrations. However, different 
strategies to account for urine dilution yielded similar results. Moreover, uncertainties in 
exposure assessment are likely to result in non-differential measurement error and to 
underestimate the associations. On the other hand, because serum creatinine is released 
from muscle mass and muscle mass is inversely correlated with frailty, creatinine 
correction could also be biasing cadmium results. Finally, we used low BMI as an 
indicator of frailty because the NHANES III lacked information on weight loss. 
However, analyses excluding the weight loss criteria from the definition of frailty and 
considering as frail those with >3 of the 4 remaining criteria, showed the same results.  
 
CONCLUSION 
 
18 
 
Exposure to lead is positively associated with frailty. Although it is difficult to 
determine the impact of age-related variations in renal function on cadmium excretion 
in the elderly, the results of this study do not support an overall association between 
cadmium exposure and frailty. Future prospective studies should confirm the observed 
results.   
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TABLES  
Table 1: Blood Lead and Urine Cadmium in participants aged 60 years and older: 
NHANES III, 1988-1994. 
Variables Blood lead levels µg/dl (N=5272)  Urine cadmium µg/L (N=4887) 
  ≤2.9 3.0-4.9 ≥5.0   ≤0.41 0.42-0.91 ≥0.92 
 n Weighted %  n Weighted % 
Male gender 2564 29.4 41.3 60.8  2418 58.4 54.4 54.2 
Age, years          
60-66 1612 37.8 37.5 33.1  1595 35.0 36.5 42.9 
67-73 1485 32.8 30.0 32.4  1427 34.2 32.6 30.0 
≥74 2175 29.4 32.5 34.5  1865 30.8 30.9 27.1 
Ethnicity          
Non-Hispanic White 3145 87.0 87.1 81.9  2831 85.9 84.9 83.2 
Non-Hispanic Black 978 5.3 6.7 11.4  961 6.5 8.2 9.6 
Mexican-American 1002 2.7 2.1 2.0  950 2.5 2.1 2.4 
Other 147 5.0 4.1 4.7  145 5.1 4.8 4.8 
Education          
<High school 2990 38.4 41.0 46.1  2722 35.7 39.8 45.5 
High school 1220 32.6 28.5 30.2  1152 29.4 30.6 32.5 
>High School 1062 29.0 30.5 23.7  1013 34.9 29.6 22.0 
BMI, kg/m2           
<25 1952 36.2 36.2 40.9  1761 37.0 35.1 39.4 
25-30 2109 37.4 39.6 39.9  1956 41.4 37.1 38.9 
≥30 1211 26.4 24.2 19.2  1170 21.6 27.8 21.7 
Tobacco smoke          
Never 2476 58.4 44.4 29.8  2272 60.4 43.2 28.3 
Former 1998 33.0 40.0 48.2  1857 33.2 43.6 45.1 
Current 798 8.6 15.6 22.0  758 6.4 13.2 26.6 
Number of smokers 
at home 
         
0 4016 84.2 78.9 70.0  3706 85.4 80.4 67.1 
1 948 12.1 15.7 21.8  885 11.9 15.9 21.9 
≥2 308 3.7 5.4 8.2  296 2.7 3.8 11.0 
Osteoarticular 
disease 
2412 48.3 46.4 39.5  2193 44.2 46.6 42.3 
Cardiovascular 
disease 
813 11.0 12.7 13.4  693 9.5 12.3 11.8 
Hypertension 2647 44.4 45.7 48.0  2460 45.3 47.8 45.1 
Chronic respiratory 
disease 
788 15.4 15.6 20.2  722 13.0 16.9 20.4 
Diabetes 821 14.8 13.4 9.4  747 12.5 12.2 11.6 
Kidney disease   1418 17.6 23.2 26.4  1320 20.8 23.8 22.5 
Cancer 450 8.4 9.2 9.4  400 8.3 8.4 9.6 
Drug treatments          
0 1525 23.9 30.3 33.2  1449 30.1 27.8 31.4 
1-2 1992 41.1 36.7 36.6  1859 39.7 39.8 36.6 
≥3 1755 35.0 33.0 30.2  1579 30.2 32.4 32.0 
 
28 
 
Table 2: Odds Ratios (95% CI) for the association between blood lead levels, urine cadmium and frailty in US older adults. 
 Lead  Cadmium 
 ≤2.9 µg/dl 
 
3-4.9 µg/dl 
 
≥5 µg/dl 
 
p-
trenda 
per intertertile 
range 
 ≤0.41 µg/l 0.42-0.91 µg/l 
 
≥0.92 µg/l 
 
p-
trenda 
per intertertile 
range 
            
Model 1* 1.00 (ref) 1.28 
(0.87;1.89) 
1.40 
(1.07;1.83) 
 
0.01 
1.16 
(1.04;1.29) 
 1.00 (ref) 1.04 
(0.76;1.43) 
1.47 
(1.02;2.12) 
 
0.04 
1.39 
(1.04-1.87) 
            
Model 2* 1.00 (ref) 1.33 
(0.88,1.99) 
1.58 
(1.19,2.10) 
 
<0.01 
1.16 
(1.04,1.29) 
 1.00 (ref) 0.98 
(0.70,1.38) 
1.40 
(0.96,2.03) 
 
0.08 
1.32 
(1.00,1.76) 
            
Model 3* 1.00 (ref) 1.40 
(0.96,2.04) 
1.75 
(1.33,2.31) 
 
<0.01 
1.20 
(1.08,1.33) 
 1.00 (ref) 0.97 
(0.68,1.39) 
1.55 
(1.03,2.32) 
 
0.04 
1.30 
(0.94,1.81) 
            
Sensitivity 
analyses 
           
            
Model 4* 1.00 (ref) 1.54 
(0.97,2.46) 
1.65 
(1.15,2.39) 
 
<0.01 
1.20 
(1.05,1.37) 
 1.00 (ref) 0.94 
(0.64,1.39) 
1.42 
(0.97,2.20) 
 
0.06 
1.36 
(0.98,1.89) 
            
Model 5 - - - - -  1.00 (ref) 0.70 
(0.45,1.09) 
1.67 
(1.05,2.66) 
 
0.03 
1.14 
(0.95,1.36) 
            
Model 6 - - - - -  1.00 (ref) 0.90 
(0.65-1.25) 
1.35 
(0.93-1.97) 
 
0.12 
1.16 
(0.88-1.51) 
            
Model 7 1.00 (ref) 1.40 
(0.89,2.19) 
1.72 
(1.20,2.47) 
 
<0.01 
1.20 
(1.05,1.39) 
 1.00 (ref) 0.70 
(0.43,1.14) 
1.09 
(0.56,2.11) 
 
0.27 
1.18 
(0.83,1.69) 
a P-values for linear trend were calculated by assigning the median value to each tertile and treating the new variable as continuous. 
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Model 1: Unadjusted.  
Model 2: Adjusted for age and sex.  
Model 3 adjusted for age, sex, education level (<high school, high school, >high school), ethnicity (Non-Hispanic White, Non-Hispanic Black, 
Mexican-American, other), body mass index, tobacco smoking  (never, former, current), number of smokers at home, osteoarticular disease, 
cardiovascular disease, hypertension, chronic respiratory disease, diabetes, cancer,  reduced glomerular filtration rate and number of drug 
treatments.  
Model 4: Model 3 adjusted for serum cotinine concentrations. Model based on 4796 (lead) or 4596 (cadmium) participants with this information 
available.  
*For cadmium, models 1-4 further adjusted for urine creatinine concentrations 
Model 5: Model 3 dividing cadmium by urine creatinine concentrations, instead of adjusting for urine creatinine concentrations  
Model 6: Model 3 neither adjusting for creatinine concentrations nor dividing by urine creatinine concentrations 
Model 7: Model 3 conducted only among participants with normal glomerular filtration rate (GFR > 60mL/min/1.73 m2); N=3854 for lead and 
N=3551 for cadmium.  
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FIGURE TITLES 
 
Figure 1: Odds Ratios (95% Confidence Intervals) of frailty according to log-
transformed blood lead and log-transformed urine cadmium based on restricted cubic 
splines with knots at the 10th, 50th and 90th of their distribution.  
 
Figure 2: Odds Ratios (95% Confidence Intervals) of the components of frailty across 
tertiles of blood lead and urine cadmium in US older adults 
 
Figure 3: Odds Ratios (95% Confidence Intervals) of frailty per intertertile range 
increase in log-transformed blood lead and urine cadmium, by the main socio-
demographic and lifestyle risk factors 
 
FIGURE LEGENDS 
 
Figure 1: Analyses for the association of lead (A) and cadmium (B) with frailty 
conducted in the overall population. Analyses for the association between cadmium (C) 
and frailty in individuals with normal kidney function (GFR>60mL/min/1.73 m2). The 
reference value is set at the 10th percentile of lead or cadmium distribution. Odds ratios 
are adjusted for age, sex, education level, ethnicity, body mass index, tobacco smoking, 
number of smokers at home, self-reported morbidity, hypertension, reduced GFR and 
number of drug treatments. Cadmium models are further adjusted for urine creatinine. 
Lines represent the Odds Ratio (thick line) and 95% Confidence Intervals (dotted lines), 
and vertical bars represent the histogram of blood lead or urine cadmium distribution, as 
appropriate. 
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Figure 2: Models are adjusted for age, sex, education level, ethnicity, body mass index, 
tobacco smoking, number of smokers at home, self-reported morbidity, hypertension, 
reduced GFR and number of drug treatments. Cadmium analyses are based on 
individuals with GFR>60mL/min/1.73 m2, with further adjustment for urine creatinine. 
 
Figure 3: Models are adjusted for age, sex, education level, ethnicity, body mass index, 
tobacco smoking, number of smokers at home, self-reported morbidity, hypertension, 
reduced GFR and number of drug treatments. Cadmium analyses are based on 
individuals with GFR>60mL/min/1.73 m2, with further adjustment for urine creatinine. 
*Cotinine models are based on the sub-sample of participants with this information 
available (N=4796 for lead; N=4596 for cadmium). 
